Core Viewpoint - The company is undergoing a significant change in its shareholding structure, with the largest shareholder, Mr. Lu Nan, transferring a substantial portion of his shares to Cangnan Xincheng, which will lead to a shift in control of the company to Mr. Wei Naixu. Group 1: Share Transfer Details - Mr. Lu Nan, the largest shareholder, will transfer 62,739,500 shares, representing 5.61% of the total share capital, to Cangnan Xincheng [1] - After the transfer, Mr. Lu's direct shareholding will decrease from 62,739,500 shares to 0 shares, while his indirect holding through Hangzhou Botai Investment Management Co., Ltd. will be 6,006,776 shares, or 0.54% of the total share capital [1] - The total share capital of the company is 1,117,872,230 shares [1] Group 2: Voting Rights Delegation - The shareholder, Sijia Wulian, has signed a voting rights delegation agreement with Cangnan Xincheng and its actual controller, Mr. Wei Naixu, to delegate voting rights for 63,890,185 shares, which is 5.72% of the total share capital [2] - The delegation of voting rights will be effective for 36 months from the date of approval by the company's shareholders' meeting [2] - Sijia Wulian and Cangnan Xincheng do not have any other related party relationships [2] Group 3: Control and Shareholding Structure Post-Transfer - Cangnan Xincheng will directly hold 62,739,500 shares after the transfer, while Mr. Wei Naixu will indirectly hold a total of 83,471,940 shares through Cangnan Xincheng and Cangnan Xinchuang, representing 7.47% of the total share capital [3] - The total number of shares with voting rights will amount to 147,362,125 shares, or 13.18% of the total share capital [3] - Following these changes, Cangnan Xincheng will become the controlling shareholder, and the company's control will shift from having no actual controller to being under the control of Mr. Wei Naixu [3]
思创医惠(300078.SZ):重新签署《股份转让协议》,苍南芯盛拟成为公司控股股东